Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Market Cap 28.23B 24.54B 22.56B 21.25B 39.79B 2,668B 40.26B 268B 104B 1,311B 106B 104B 4,532B P/E 2026 *
29.9x
P/E 2027 * 25x
Enterprise Value 27.86B 24.22B 22.26B 20.97B 39.27B 2,633B 39.73B 265B 103B 1,293B 105B 102B 4,473B EV / Sales 2026 *
5.33x
EV / Sales 2027 * 4.63x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 week-6.49%
Current month+0.32%
1 month+19.81%
3 months+9.34%
6 months+11.74%
Current year+10.55%
1 week 62.01
Extreme 62.01
68
1 month 52.58
Extreme 52.58
68.1
3 years 46.85
Extreme 46.85
132
5 years 46.85
Extreme 46.85
144.8
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-1.82%-6.49%-11.99%-46.83% 28.23B
-2.34%-3.01%-33.96%-16.67% 158B
-3.91%-4.68%-11.12%-12.35% 104B
+2.05%+7.87%+67.60%+57.74% 56.43B
-1.55%-0.89%-5.27%+51.41% 54.76B
-2.45%-6.86%-17.72%-45.25% 40B
-1.81%+1.14% - - 31.36B
-1.82%-3.31%+44.27%-10.62% 23.28B
+1.17%-1.66%-13.50%-2.88% 20.41B
-3.44%-6.33%-17.32%-6.65% 20.13B
Average -1.57%-0.44%+0.11%-3.57% 56.51B
Weighted average by Cap. -1.95%-0.15%-7.19%-2.81%

Financials

2026 *2027 *
Net sales 5.22B 4.54B 4.17B 3.93B 7.36B 494B 7.45B 49.61B 19.26B 243B 19.61B 19.19B 839B 5.83B 5.07B 4.66B 4.39B 8.22B 551B 8.31B 55.36B 21.5B 271B 21.88B 21.41B 936B
Net income 963M 837M 769M 725M 1.36B 90.98B 1.37B 9.14B 3.55B 44.69B 3.61B 3.54B 155B 1.16B 1.01B 925M 871M 1.63B 109B 1.65B 10.99B 4.27B 53.75B 4.34B 4.25B 186B
Net Debt -370M -321M -295M -278M -521M -34.92B -527M -3.51B -1.36B -17.15B -1.39B -1.36B -59.32B -1.25B -1.08B -997M -939M -1.76B -118B -1.78B -11.85B -4.6B -57.92B -4.68B -4.58B -200B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
-
Date Price Change
17/06/26 62.06 -1.82%
16/06/26 63.21 -1.54%
15/06/26 64.20 -1.29%
12/06/26 65.04 -0.25%
11/06/26 65.20 +0.46%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
73.16USD
Average target price
85.21USD
Spread / Average Target
+16.47%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!